Study supports weekly buprenorphine during and after pregnancy

Key Points

• This study aims to evaluate the effectiveness of weekly extended-release buprenorphine for treating opioid use disorder during pregnancy.
• Evaluated weekly extended-release buprenorphine treatment during pregnancy for opioid use disorder.
• Assessed outcomes throughout pregnancy and postpartum.
• Demonstrated improved treatment adherence with weekly buprenorphine during pregnancy.
• Found positive outcomes in maternal and neonatal health indicators.